Impact News +++ Daimler Truck meldet starkes EBIT für Q3 2025 trotz Marktherausforderungen (Investing.com DE) +++ DAIMLER TRUCK Aktie -3,03%

GLOBUS MEDICAL Aktie

>GLOBUS MEDICAL Aktienkurs

68 EUR +27.1% (Tradegate)

Ask: 68 EUR / 74 Stück

Bid: 65 EUR / 78 Stück

Tagesumsatz: 70 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

GLOBUS MED Aktie über LYNX handeln

Intraday

1 Jahr

>GLOBUS MEDICAL Performance

1 Woche: -0,9%

1 Monat: +2,9%

3 Monate: +13,6%

6 Monate: -15,0%

1 Jahr: -30,0%

laufendes Jahr: -34,0%

>GLOBUS MEDICAL Aktie

Name:

GLOBUS MED.A NEW DL -,001

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US3795772082 / A1J2LY

Symbol/ Ticker:

GM0N (Frankfurt) / GMED (NYSE)

Kürzel:

FRA:GM0N, ETR:GM0N, GM0N:GR, NYSE:GMED

Index:

Webseite:

http://www.globusmedical...

Profil:

Globus Medical Inc. is a leading medical device co..
>Volltext..

Marktkapitalisierung:

7213.11 Mio. EUR

Unternehmenswert:

7121.6 Mio. EUR

Umsatz:

2280.62 Mio. EUR

EBITDA:

551.38 Mio. EUR

Nettogewinn:

309.69 Mio. EUR

Gewinn je Aktie:

2.28 EUR

Schulden:

105.42 Mio. EUR

Liquide Mittel:

199.23 Mio. EUR

Operativer Cashflow:

581.05 Mio. EUR

Bargeldquote:

0.54

Umsatzwachstum:

6.78%

Gewinnwachstum:

697.26%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

GLOBUS MEDICAL, GLOBUS MED

Letzte Datenerhebung:

07.11.25

>GLOBUS MED Kennzahlen

Aktien/ Unternehmen:

Aktien: 112.62 Mio. St.

Frei handelbar: 99.29%

Leerverk. Aktien: 5.62%

Rückkaufquote: 1.3%

Mitarbeiter: 5300

Umsatz/Mitarb.: 0.41 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 27.91%

Bewertung:

KGV: 23.87

KGV lG: 18.82

KUV: 3.29

KBV: 1.94

PEG-Ratio: 0.03

EV/EBITDA: 12.92

Rentabilität:

Bruttomarge: 58.23%

Gewinnmarge: 13.58%

Operative Marge: 13.83%

Managementeffizenz:

Gesamtkaprendite: 7.17%

Eigenkaprendite: 8.62%

>GLOBUS MED Peer Group

Es sind 597 Aktien bekannt.

>GLOBUS MEDICAL Chart & Kurs - NYSE

>GLOBUS MEDICAL News

07.11.25 - 04:03	Globus Medical raises 2025 EPS guidance to $3.75–$3.85 as Nevro integration accelerates profitability (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

07.11.25 - 03:15	Globus Medical (GMED) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
	The headline numbers for Globus Medical (GMED) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals....

07.11.25 - 02:30	Globus Medical (GMED) Tops Q3 Earnings and Revenue Estimates (Zacks)
	Globus Medical (GMED) delivered earnings and revenue surprises of +49.37% and +4.85%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?...

07.11.25 - 00:12	Globus Medical übertrifft Prognosen im dritten Quartal – Aktie legt zu (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

06.11.25 - 22:33	Globus Medical Non-GAAP EPS of $1.18 beats by $0.41, revenue of $769M beats by $34.33M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

06.11.25 - 22:18	Globus Medical Reports Third Quarter 2025 Results (GlobeNewswire EN)
	AUDUBON, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2025....

31.10.25 - 16:45	Prescription for Beats: 3 Healthcare Stocks Set to Outperform in Q3 (Zacks)
	Humana, Cencora and Globus Medical are poised to outshine in the September quarter, driven by strong demand, innovation and volume growth....

16.10.25 - 22:33	Globus Medical Schedules Third Quarter Earnings Release and Conference Call (GlobeNewswire EN)
	AUDUBON, Pa., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the third quarter ended September 30, 2025 after the market close on Thursday, November 6, 2025. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com....

14.10.25 - 22:42	Globus Medical Launches ANTHEM™ Elbow Fracture System: A Comprehensive Plating Portfolio for Complex Elbow Trauma (GlobeNewswire EN)
	AUDUBON, Pa., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, has announced the launch of the ANTHEM™ Elbow Fracture System, a fully comprehensive plating portfolio designed to address a wide spectrum of elbow fractures....

17.09.25 - 04:01	Insiderhandel: Aufsichtsrat verkauft Aktien von Globus Medical im Wert von 584600 USD (Insiderkauf)
	Rhoads, Ann D. - Aufsichtsrat - Tag der Transaktion: 2025-09-15...

04.09.25 - 19:45	Should You Hold Onto Globus Medical Stock in Your Portfolio for Now? (Zacks)
	GMED rides strong musculoskeletal demand and new launches, but faces currency headwinds and fierce competition....

29.08.25 - 17:12	Globus Medical wins favorable jury verdict in patent dispute with Life Spine (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

28.08.25 - 22:33	Globus Medical, Inc. Secures Jury Verdict in Delaware Patent Litigation Against Life Spine, Inc. (GlobeNewswire EN)
	AUDUBON, Pa., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, announced that a Delaware jury has returned a verdict in favor of Globus in its patent infringement litigation against Life Spine, Inc....

13.08.25 - 16:00	Globus Medical Stock Up on Q2 Earnings & Revenue Beat, Margins Expand (Zacks)
	GMED posts strong Q2 with earnings and revenues, boosted by the Nevro acquisition and expanded margins....

08.08.25 - 21:09	Globus Medical reaffirms $2.8B–$2.9B 2025 sales outlook as integration advances and U.S. Spine momentum builds (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

08.08.25 - 02:30	Globus Medical (GMED) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
	Although the revenue and EPS for Globus Medical (GMED) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers....

08.08.25 - 01:00	Globus Medical (GMED) Q2 Revenue Up 18% (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

07.08.25 - 22:18	Globus Medical Reports Second Quarter 2025 Results (GlobeNewswire EN)
	AUDUBON, Pa., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30, 2025....

21.07.25 - 14:51	Globus Medical appoints Keith Pfeil as CEO (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

21.07.25 - 14:03

Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results (GlobeNewswire EN)

AUDUBON, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced that Keith Pfeil, Executive Vice President, Chief Operating Officer and Chief Financial Officer, has been appointed President and Chief Executive Officer effective July 18, 2025. Daniel Scavilla has resigned as President and Chief Executive Officer effective July 18, 2025, in order to pursue another opportunity. Additionally, Kyle Kline, Senior Vice President of Finance, has been appointed Senior Vice President and Chief Financial Officer....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Bildung scheint mir das einzige Ziel, das des Bestrebens, Wahrheit der einzige Reichtum, der des Besitzes würdig ist. - Heinrich von Kleist

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram